newsfilter
← Latest News
PR Newswire·

Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

Successful top line results from Phase 2a clinical trial for lead candidate LP-10 Oral Health Scientific Advisory Board established to focus on development of LP-310 for oral lichen planus Late-breaking presentation of